Resignation and Appointment of Company Secretary
Released
Released
Announcement PDF
®
IMAGION BIOSYSTEMS LIMITED
(ASX: IBX)
8 December 2020
Resignation and Appointment of Company Secretary
MELBOURNE — Imagion Biosystems Limited (ASX: IBX) (Imagion or the Company) announces that
that Ms Jovanka Naumoska has resigned from her position as Company Secretary of Imagion, effective
today, 8 December 2020. Ms Naumoska will remain on the Board as a Non-Executive Director.
The Company has appointed Mr Geoff Hollis as Company Secretary, effective today. Mr Hollis was
recently appointed as the Company’s Chief Financial Officer.
The Board would like to thank Ms Naumoska for her valued contribution as Company Secretary.
-ENDS
About Imagion Biosystems
Imagion Biosystems is developing a new non-radioactive and safe diagnostic imaging technology.
Combining biotechnology and nanotechnology the Company aims to detect cancer and other diseases
earlier and with higher specificity than is currently possible. Imagion Biosystems listed on the Australian
Securities Exchange (ASX) in June 2017.
This Announcement has been approved by the Disclosure Committee of Imagion Biosystems
Limited
For further information please visit www.imagionbiosystems.com
U.S. Media Contact:
Matthew Wygant
matthew@biotechwriting.com
+1-408-905-7630
Australian Media & Investor Relations:
Kyahn Williamson, WE Communications
We-AUImagionBiosystems@we-worldwide.com
+61-3-9866-4722
Imagion Biosystems Limited
ACN 616 305 027
Level 25, 525 Collins Street, Melbourne VIC 3000
www.imagionbiosystems.com
Share your feedback
Discover